Guardant Health Inc (GH) financials
Guardant Health revenue and earnings by year
Guardant Health's revenue was $982 million in the fiscal year to December 31, 2025, up 32.9% from the year before. Net income was -$416 million, -42.4% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 50.2% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 982 | 739 | 564 | 450 | 374 | 287 | 214 | 91 | 50 | 25 |
| Revenue growth | 32.9% | 31.0% | 25.5% | 20.3% | 30.3% | 33.8% | 136.5% | 81.9% | 97.4% | — |
| Gross profit | 633 | 449 | 337 | 293 | 251 | 194 | 144 | 47 | 18 | 3 |
| Gross margin | 64.5% | 60.8% | 59.7% | 65.2% | 67.1% | 67.7% | 67.0% | 52.3% | 36.6% | 12.4% |
| Operating income | -437 | -444 | -565 | -544 | -411 | -255 | -82 | -93 | -77 | -44 |
| Operating margin | -44.5% | -60.0% | -100.1% | -121.1% | -110.0% | -88.9% | -38.4% | -102.5% | -153.7% | -173.7% |
| Net income | -416 | -436 | -479 | -655 | -406 | -254 | -76 | -85 | -83 | -46 |
| Net margin | -42.4% | -59.0% | -85.0% | -145.6% | -108.6% | -88.5% | -35.3% | -93.8% | -167.0% | -182.7% |
| Diluted EPS | -$3.32 | -$3.56 | -$4.28 | -$6.41 | -$4.00 | -$2.58 | -$0.85 | — | — | — |
| Free cash flow | -233 | -275 | -345 | -387 | -284 | -158 | -68 | -92 | -79 | -38 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open GH in Markets.
How Guardant Health makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Oncology | $219M | 65.4% |
| Biopharma Data | $60.9M | 18.2% |
| Screening | $52.9M | 15.8% |
| Licensing Other | $2.06M | 0.6% |
See also: GH returns
No forecast, no recommendation. This page describes Guardant Health Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.